Amirim, Israel-based-based Via Surgical’s FasTouch is designed for the fixation of prosthetic material to soft tissue, providing lockable, flexible suture-like fixation for procedures such as hernia repairs.
“The FasTouch System provides innovation in hernia fixation with the potential to allow for reduced patient pain and improve outcomes while reducing cost by maximizing efficiency with the use of exchangeable cartridges. We are excited to partner with Via Surgical to offer an innovative product designed to improve outcomes and quality of care, our mission and commitment to the patients and customers we serve,” Progressive Medical prez Mark Martin said in prepared remarks.
The device uses exchangeable cartridges which the company said provides “increased value and cost saving over traditional fixation devices.”
“We are excited to have Progressive Medical as our exclusive US distributor partner, Progressive Medical with its outstanding track record, surgical focus and extensive national coverage is an ideal partner to introduce FasTouch, a novel and very promising surgical fixation technology,” Via Surgical CCO John Gomes said in a press release.
In February, Via Surgical said it raised $6 million in a funding round to support its FasTouch suture device. Benslie Investment Group led the round, with managing partner Nicolas Weinstein joining Via Surgical’s board.